Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBLGNASDAQ:DHAINASDAQ:INBSNASDAQ:STRR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBLGBone Biologics$0.73-1.4%$0.75$0.57▼$4.25$2.39M0.531.39 million shs32,838 shsDHAIDIH Holding US$0.22-8.0%$0.22$0.12▼$3.67$10.31M-0.14385,929 shs473,811 shsINBSIntelligent Bio Solutions$1.24-3.5%$1.47$1.00▼$3.00$8.45M4.63551,554 shs70,721 shsSTRRStar Equity$2.35$2.18$1.72▼$5.35$7.56M0.8714,906 shs18,828 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBLGBone Biologics-4.52%+9.63%+5.70%-28.16%-67.83%DHAIDIH Holding US+24.64%+33.20%+56.75%-62.90%-85.11%INBSIntelligent Bio Solutions-5.51%+12.23%+1.18%-45.78%-46.23%STRRStar Equity+4.44%-0.21%+17.50%+10.33%-47.78%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBLGBone Biologics1.3346 of 5 stars0.04.00.00.03.60.01.3DHAIDIH Holding US0.7278 of 5 stars0.03.00.00.03.31.70.0INBSIntelligent Bio Solutions0.4611 of 5 stars0.03.00.00.02.40.00.6STRRStar Equity3.2256 of 5 stars3.55.00.00.01.71.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBLGBone Biologics 0.00N/AN/AN/ADHAIDIH Holding US 0.00N/AN/AN/AINBSIntelligent Bio Solutions 0.00N/AN/AN/ASTRRStar Equity 3.00Buy$5.00112.77% UpsideCurrent Analyst Ratings BreakdownLatest BBLG, DHAI, INBS, and STRR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025STRRStar EquityMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $5.00(Data available from 5/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBLGBone BiologicsN/AN/AN/AN/A$7.42 per shareN/ADHAIDIH Holding US$64.47M0.16N/AN/A($0.80) per share-0.27INBSIntelligent Bio Solutions$3.03M2.79N/AN/A$0.80 per share1.55STRRStar Equity$53.36M0.14$0.38 per share6.11$14.63 per share0.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBLGBone Biologics-$8.95MN/A0.00N/AN/AN/A-124.71%-111.64%N/ADHAIDIH Holding US-$8.44M-$0.30N/A∞N/A-13.59%-5.07%-25.97%N/AINBSIntelligent Bio Solutions-$10.16MN/A0.003.54N/A-323.79%-146.03%-83.62%N/ASTRRStar Equity$25.13M-$3.43N/AN/AN/A-12.41%-8.72%-4.62%N/ALatest BBLG, DHAI, INBS, and STRR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025STRRStar Equity-$0.25-$0.52-$0.27-$0.37$16.35 million$12.92 million5/12/2025Q1 2025BBLGBone Biologics-$0.48-$0.32+$0.16-$0.32N/AN/A3/20/2025Q4 2024STRRStar Equity-$0.17$0.15+$0.32-$0.94$14.00 million$17.10 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBLGBone BiologicsN/AN/AN/AN/AN/ADHAIDIH Holding USN/AN/AN/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBLGBone BiologicsN/A14.8914.89DHAIDIH Holding USN/A0.510.41INBSIntelligent Bio SolutionsN/A0.920.76STRRStar Equity0.212.051.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBLGBone Biologics34.30%DHAIDIH Holding US27.76%INBSIntelligent Bio Solutions32.97%STRRStar Equity3.84%Insider OwnershipCompanyInsider OwnershipBBLGBone Biologics6.10%DHAIDIH Holding US49.58%INBSIntelligent Bio Solutions1.54%STRRStar Equity33.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBLGBone Biologics23.27 million2.31 millionNot OptionableDHAIDIH Holding USN/A47.34 million20.44 millionN/AINBSIntelligent Bio Solutions106.81 million5.26 millionNot OptionableSTRRStar Equity4603.22 million2.14 millionNot OptionableBBLG, DHAI, INBS, and STRR HeadlinesRecent News About These CompaniesStar Equity signals record $27.9M backlog while advancing Energy Services integrationMay 15 at 3:21 PM | msn.comStar Equity Holdings Inc (STRR) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 15 at 3:21 PM | finance.yahoo.comStar Equity Holdings, Inc. (NASDAQ:STRR) Q1 2025 Earnings Call TranscriptMay 15 at 9:28 AM | insidermonkey.comStar Equity Holdings, Inc. (STRR) Q1 2025 Earnings Call TranscriptMay 14 at 3:15 PM | seekingalpha.comStar Equity (STRR) Reports Q1 Loss, Misses Revenue EstimatesMay 14 at 10:50 AM | zacks.comStar Equity Holdings, Inc. Announces 2025 First Quarter Financial Results | STRR Stock NewsMay 14 at 9:17 AM | gurufocus.comStar Equity Holdings, Inc. Announces 2025 First Quarter Financial ResultsMay 14 at 9:17 AM | gurufocus.comStar Equity Holdings, Inc. Announces 2025 First Quarter Financial ResultsMay 14 at 8:30 AM | globenewswire.com7STRR : A Preview Of Star Equity Hldgs's EarningsMay 13 at 5:15 PM | benzinga.comStar Equity (STRR) to Release Earnings on MondayMay 12 at 4:03 AM | americanbankingnews.comStar Equity Holdings to Release First Quarter 2025 Financial Results on May 14thMay 7, 2025 | globenewswire.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Procaps Group (OtherPROCF) and Star Equity Holdings (STRR)March 26, 2025 | markets.businessinsider.comStar Equity Holdings, Inc. (NASDAQ:STRR) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | msn.comStar Equity Holdings Reports Mixed Q4 Earnings ResultsMarch 21, 2025 | tipranks.comStar Equity reports Q4 EPS 15c vs (10c) last yearMarch 21, 2025 | markets.businessinsider.comStar Equity Holdings, Inc. (STRR) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comStar Equity (STRR) Q4 Earnings and Revenues Top EstimatesMarch 20, 2025 | zacks.comStar Equity Holdings, Inc. Announces 2024 Fourth Quarter and Full Year Financial ResultsMarch 20, 2025 | gurufocus.comStar Equity Holdings, Inc. Announces 2024 Fourth Quarter and Full Year Financial ResultsMarch 20, 2025 | globenewswire.comStar Equity Holdings, Inc. to Announce Fourth Quarter 2024 Financial Results on March 20, 2025March 13, 2025 | quiverquant.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBBLG, DHAI, INBS, and STRR Company DescriptionsBone Biologics NASDAQ:BBLG$0.73 -0.01 (-1.45%) As of 04:00 PM EasternBone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.DIH Holding US NASDAQ:DHAI$0.22 -0.02 (-8.03%) As of 03:59 PM EasternDIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.Intelligent Bio Solutions NASDAQ:INBS$1.24 -0.05 (-3.50%) As of 04:00 PM EasternIntelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Star Equity NASDAQ:STRR$2.35 0.00 (0.00%) As of 03:56 PM EasternStar Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas An Acquisition Just Made Dick's the Most Exciting Stock in Retail Walmart Stock Alert: Big Price Move Expected Soon Broadcom Set to Surge as AI Diffusion Rule Ends Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins Is Bally’s Turnaround a Safe Bet Amid Mixed Investor Sentiment? SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start Intel Makes a Cool Move With Shell, But Will Investors Warm Up? AMD’s AI-Powered Stock Price Rally Just Shifted Gears Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
